Finnish game developer Remedy has released its latest earnings report, and included in the filing are some key updates for ...

Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...

Royal Bank of Canada reissued their outperform rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. They ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report) had its price target lowered by equities researchers at Needham & Company LLC from $38.00 to $10.00 in a report released on Monday,Benzinga reports.

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Fintel reports that on February 10, 2025, Citigroup downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from Buy ...

FINN offers vehicles from over 30 brands with an all-inclusive service covering insurance, financing, registration, taxes, and maintenance.

Fintel reports that on February 7, 2025, Citigroup initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Neutral ...

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

Palantir Technologies shares are trading at all-time highs on Thursday on what appears to be continued momentum in the wake of the company's strong fourth-quarter financial results. Here's what you ...

Leonteq AG (SIX: LEON) today announced the appointment of Christian Spieler as Leonteq’s CEO effective 1 March 2025.